Age: Addressing a Blind Spot in Cancer Care

In the last decade, we have seen breakthrough progress in our ability to help prevent, diagnose, and treat cancer. But today, too many people living with cancer still face barriers to timely and equitable care. At Pfizer, we’re focused on removing those barriers for all people living with cancer — including those over the age of 65 — to address disparities in cancer care and improve health equity.

Read the full article.